SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Sugar Ray Robinson

PatientSugar Ray Robinson
Date of birth1963-05-03
IdentifiersMRN HR-BX003-SYN; SSN (made up) 000-03-9318
Document date2026-09-22
AuthorLangston Pryce-Okonjo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eleven-week review: donepezil, diabetes, hearing aids and day program. [S]

History of Present Illness

Sugar Ray Robinson returns eleven weeks after intake with his care partner, two weeks after his preventive visit. He has taken donepezil 5 mg at bedtime for five weeks without nausea, diarrhea or dizziness. Off glipizide, his home glucose readings run 120 to 170 mg/dL with no low readings. The hearing aids help most in conversation. He started the adult day program two days a week and likes the exercise group. The dilated eye examination booked after intake was missed: the clinic called the day before, but nobody at home remembered on the morning, and he no longer drives himself. He would like his Tdap today. [S]

ElementDetail
Donepezil5 mg for five weeks; no side effects
Hemoglobin A1c6.9%, from 6.4%
Home glucose120 to 170 mg/dL; no lows
Hearing aidsWorn daily
Eye examinationMissed

Review of Systems

SystemResultFinding
GastrointestinalNegativeNo nausea, diarrhea or weight loss
CardiovascularNegativeNo dizziness or fainting
NeurologicalPositiveMemory loss unchanged; no falls
PsychiatricNegativeMood good; enjoys the day program

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1,000 mg oral tablet, one tablet twice daily with mealsOne tablet twice daily with mealsOral route2024-03-01activeS
Glipizide 5 mg oral tablet, one tablet before breakfastOne tablet before breakfastOral route2025-01-15 to 2026-08-18completedS
Lisinopril 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2023-06-01activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2024-03-01activeS
Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counterOne capsule at bedtimeOral route2025-10-01 to 2026-07-07stoppedS
Donepezil 5 mg oral tablet, one tablet at bedtimeOne tablet at bedtimeOral route2026-08-18 to 2026-09-22completedS
Donepezil 10 mg oral tablet, one tablet at bedtimeOne tablet at bedtimeOral route2026-09-22 to 2026-10-01stoppedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-22Body height180cmS
2026-09-22Body weight76.2kgS
2026-09-22Body mass index (BMI) [Ratio]23.5kg/m2S
2026-09-22Systolic blood pressure128mm[Hg]S
2026-09-22Diastolic blood pressure76mm[Hg]S
2026-09-22Heart rate64/minS
2026-09-22Respiratory rate14/minS
2026-09-22Body temperature36.6CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-22Hemoglobin A1c/Hemoglobin.total in Blood6.9%<=5.6%HighS

Physical Exam

Vital signs recorded on 2026-09-22; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/76; pulse 64 and regular; weight 76.2 kg
Mental statusCheerful; follows conversation better with the hearing aids
GaitSteady

Problems

ProblemClinical statusVerificationCodeProvenance
Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be foundresolvedconfirmed R41.3S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.
Alzheimer's disease with early onset, confirmed by a positive amyloid PET, with an amnestic presentation; traumatic encephalopathy syndrome, a research diagnosis, consideredactiveconfirmed G30.0S — Synthetic modern diagnosis by current criteria at the third visit; not a retrospective diagnosis of the historical person beyond the documented Alzheimer's disease.
Mild dementia due to Alzheimer's disease (CDR 1, MMSE 22, MoCA 18), without behavioral or psychological symptomsactiveconfirmed F02.A0S — Synthetic stage at diagnosis.
Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylureaactiveconfirmed E11.9S — Synthetic modern diabetes anchored to his documented diabetes.
Hypertension, controlled on lisinoprilactiveconfirmed I10S — Synthetic modern hypertension anchored to the single press report.
Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometryactiveconfirmed H90.3S — Synthetic finding checked as a modifiable contributor to cognitive difficulty.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyCognitive testing (MoCA, MMSE)At diagnosis, then yearly, or sooner with changeUp to dateNext in a year
Medication safetyMedicine review for anticholinergic and sedating drugs (Beers)Every visitCompleted todayNo anticholinergic or sedating drugs
SurveyBehavioral and psychological symptoms (NPI-Q items)Every visitCompleted todayNone
Medication safetyCholinesterase inhibitor: benefit, nausea, diarrhea, dreams, pulseEach follow-up and each dose changeCompleted todayFive weeks on 5 mg without side effects; pulse 64; raised to 10 mg today
Self-managementDriving, firearm and home safetyAt diagnosis and each follow-upCompleted todayNot driving; no firearm in the home; stove shut-off fitted
Self-managementCare partner support and burden (Zarit, narrative)At diagnosis, then at least yearlyCompleted todayAdult day program two days a week; caregiver class started
Self-managementAdvance care planningAt diagnosis; revisit yearly and at changesUp to dateCompleted at the preventive visit two weeks ago
LaboratoryHemoglobin A1c, goal under 8.0% for an older adult with cognitive impairment, and hypoglycemia reviewEvery three months after a therapy change; every six months when stableCompleted today6.9%, from 6.4%, off glipizide; no low readings
ExaminationBlood pressure, goal under 130/80 mmHgEvery visitCompleted today128/76 mmHg
LaboratoryPotassium and creatinine on lisinopril and metforminYearly, and after acute illness or dehydrationUp to dateNormal at intake
ExaminationDilated diabetic eye examinationEvery one to two years without retinopathyDeferredThe dilated eye examination requested at intake was missed because he no longer drives and the appointment was forgotten on the morning. No harm is known: he has no visual symptoms and his diabetes is well controlled, but retinopathy cannot be excluded until he is examined. Corrective action: re-booked with paratransit, a same-morning reminder call to his care partner, and the appointment added to the day program's calendar
Self-managementExercise and social activityEvery visitCompleted todayDay program exercise group and daily walks

Goal progress:

Immunizations given today: Tdap vaccine, deferred from the preventive visit at his request [S]

Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs (2026); 13. Older Adults: Standards of Care in Diabetes-2026 (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Practice Parameter update: Evaluation and management of driving risk in dementia (2010); Adult Immunization Schedule by Age (2026)

Follow-up: Tdap given today. Eye examination as re-booked. Sixteen-week review in five weeks. Call for side effects of the higher donepezil dose. Next scheduled visit 2026-10-27: sixteen-week review: medicines, kidneys, mood, caregiver strain and the plan. [S]